Repligen Presentations & Investor Relations material
Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biological drugs, mainly monoclonal antibodies. Our manufacturing facilities are located at our Waltham, Massachusetts headquarters in the USA, and in Lund, Sweden, Weingarten, Germany and Shrewsbury, MA. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.
repligen.comRepligen presentations

Repligen to Acquire Metenova AB

Repligen

Investor Presentation

Repligen

40th Annual J.P. Morgan Healthcare Conference Presentation

Repligen

Repligen Company Presentation

Repligen

Repligen Announces Agreement to Acquire ARTeSYN Biosolutions

Repligen
Investor Presentation

Repligen
41st Annual J.P. Morgan Healthcare Conference

Repligen

Investor Day 2022 Nasdaq MarketSite

Repligen
Investor Presentation

Repligen

Investor Presentation

Repligen

Investor Presentation

Repligen

Repligen Announces Agreement to Acquire Polymem S.A

Repligen
Categories
Finance PresentationsTechnology PresentationsBanking PresentationsInformation Technology PresentationsOil and Energy PresentationsInternet PresentationsMining and Metals PresentationsCommunications PresentationsReal Estate PresentationsBiotechnology PresentationsAutomotive PresentationsMedical PresentationsRetail PresentationsEnergy Presentations